Digital health coaching platform Numan secures $60m funding

Digital healthcare platform Numan has raised $60 million (£44.8m) in new funding, which will be used to expand into female health.

Numan‘s preventative health platform has so far been aimed at men’s health including erectile dysfunction, hair loss and obesity, using proprietary technology and data that integrates diagnostics, medication, expert care and behavioural change.

The financing is an extension of Numan’s Series B round and includes $27m (£20m)  in growth capital from HSBC Innovation Banking UK. Plus, a $30m equity investment led by Big Pi Ventures, with contributions from Endeavor Catalyst and existing investors White Star Capital and Novator Partners.

Sokratis Papafloratos, chief executive of Numan, said: “Our latest funding is a testament to both our commercial performance and belief in our long-term vision for providing personalised, preventative health at scale.

“With the fresh conviction of Big Pi Ventures, Endeavor Catalyst and HSBC Innovation Banking – as well as the continued backing of White Star Capital and our long-term investors – we are now perfectly positioned to expand our reach, deepen our clinical capabilities, and accelerate innovation to help our patients live happier, healthier, longer lives.” 

He added: “Over the past 18 months we’ve seen an explosion in demand – our patients have shown incredible engagement and achieved life-changing outcomes.

“This interest fuelled our growth and success in both reaching and maintaining profitability. That’s why we believe now is the time to invest in scaling what works and innovating for the future of healthcare.”

The new capital will support Numan’s growth, including an expansion into female health and in deepening patient relationships through enhanced screening and preventative care programmes.

It is also expected to help Numan’s growth in the UK and facilitate its international expansion.

The company plans to use the funding towards scaling the platform’s infrastructure to serve its growing patient base, expanding marketing efforts and advancing its AI capabilities.

Nick Kalliagkopoulos, partner at Big Pi Ventures, said: “The team’s focus on preventative care, patient engagement, and scalable technology sets Numan apart in the digital health sector.

“We’re confident that this infusion of capital will help Numan consolidate its leadership in the UK and pave the way for international expansion.”

Numan says that it has treated more than 650,000 patients across areas such as obesity management, men’s health and diagnostics. The firm reported $90m (£66.6m) in revenue for 2024 and is on track to achieve 150% growth in 2025.

Michael White, head of life sciences at HSBC Innovation Banking UK, said: “Our team is committed to backing bold innovators, like Numan, equipping them with the tools they need to help them reach their next milestones.

“We look forward to seeing Numan continue to expand its reach across the UK and beyond.”

In January 2025, Numan announced the launch of its AI Health Assistant which is aimed at bolstering the firm’s holistic approach to weight management through health coaching.